TY - JOUR
T1 - 'Salvage cytoreductive surgery for pelvic side wall recurrent endometrial cancer: Robotic combined laterally extended endopelvic resection (LEER) and laterally extended pelvic resection (LEPR) debulking'
AU - Di Donna, Mariano Catello
AU - Cucinella, Giuseppe
AU - Cucinella, Gabriele
AU - Zaccaria, Giulia
AU - Laganà, Antonio Simone
AU - Scambia, Giovanni
AU - Chiantera, Vito
PY - 2022
Y1 - 2022
N2 - Endometrial cancer is the most common gynecological malignancy, and most patients present at
an early-stage. However, approximately 15% of
confined-uterus endometrial cancer patients will see
their cancer return. Treatment options for recurrent
endometrial cancer depend on the patient’s level of
fitness, tumor dissemination and prior treatment. For
localized resectable pelvic disease, salvage cytoreductive surgery may improve survival.1
Laterally
extended endopelvic resection, en-bloc resection of
the pelvic tumor and sidewall structures, represents
an option for salvage treatment in cases of isolated
recurrence involving the pelvic side wall.2
AB - Endometrial cancer is the most common gynecological malignancy, and most patients present at
an early-stage. However, approximately 15% of
confined-uterus endometrial cancer patients will see
their cancer return. Treatment options for recurrent
endometrial cancer depend on the patient’s level of
fitness, tumor dissemination and prior treatment. For
localized resectable pelvic disease, salvage cytoreductive surgery may improve survival.1
Laterally
extended endopelvic resection, en-bloc resection of
the pelvic tumor and sidewall structures, represents
an option for salvage treatment in cases of isolated
recurrence involving the pelvic side wall.2
KW - Cytoreduction surgical procedures
KW - Endometrial Neoplasms
KW - Gynecologic Surgical Procedures
KW - Lymph Nodes
KW - Neoplasm Recurrence, Local
KW - Cytoreduction surgical procedures
KW - Endometrial Neoplasms
KW - Gynecologic Surgical Procedures
KW - Lymph Nodes
KW - Neoplasm Recurrence, Local
UR - http://hdl.handle.net/10807/283498
U2 - 10.1136/ijgc-2022-003746
DO - 10.1136/ijgc-2022-003746
M3 - Article
SN - 1048-891X
VL - 33
SP - 126
EP - 127
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
ER -
